
52.71 Delayed Data As of Aug 18 | ![]() Today’s Change | 47.88 Today|||52-Week Range 67.76 | -19.42% Year-to-Date |
Intercept (ICPT) Settles Litigation With Dr. Reddy's for Ocaliva Aug 18 / Zacks.com - Paid Partner Content |
Previous close | 52.73 |
Today’s open | 52.13 |
Day’s range | 52.13 - 52.77 |
Volume | 216,623 |
Average volume (3 months) | 192,000 |
Market cap | $8.8B |
Earnings growth (last year) | +36.18% |
Earnings growth (this year) | +33.25% |
Earnings growth (next 5 years) | +22.00% |
Revenue growth (last year) | +12.59% |
P/E ratio | 23.5 |
Price/Sales | 3.22 |
Price/Book | 3.51 |
Today’s change | Today’s % change | |
---|---|---|
SRPTSarepta Therapeutics... | -0.35 | -0.32% |
KRTXKaruna Therapeutics ... | -0.22 | -0.08% |
JAZZJazz Pharmaceuticals... | -1.05 | -0.67% |
UTHRUnited Therapeutics ... | +1.81 | +0.82% |
Next reporting date | October 28, 2022 |
EPS forecast (this quarter) | $0.54 |
Annual revenue (last year) | $2.9B |
Annual profit (last year) | $316.3M |
Net profit margin | 10.99% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Hyderabad, Telangana |